Antibodies Drug Market
Antibodies Drug Market
The global antibodies drug market size was calculated at USD 245.75 billion in 2024, to reach USD 272.3 billion in 2025 is expected to be worth USD 685.33 billion by 2034, expanding at a CAGR of 10.8% from 2024 to 2034.
Report ID: 10010
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 245.75 Bn
Forecast Year,
USD USD 685.33 Bn
CAGR, 2025 -
10.8%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Antibodies Drug Market Size Analysis
Antibodies Drug Market Size By Source 2024 to 2034 (USD )
| Source | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Human mAb | 86.96 | 92.78 | 105.67 | 118.37 | 126.26 | 145.02 | 157.39 | 177.04 | 196.79 | 213.14 | 237.76 |
| Humanized mAb | 72.60 | 84.49 | 92.64 | 100.30 | 114.39 | 120.55 | 137.19 | 150.06 | 164.09 | 187.20 | 206.77 |
| Chimeric mAb | 47.70 | 55.57 | 61.09 | 65.14 | 75.31 | 82.39 | 94.32 | 101.03 | 111.85 | 123.45 | 140.97 |
| Murine mAb | 38.50 | 39.45 | 42.31 | 50.48 | 54.42 | 62.43 | 65.81 | 75.70 | 85.50 | 94.73 | 99.82 |
Antibodies Drug Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Monoclonal Antibodies (mAbs) | 209.22 | 230.30 | 258.15 | 285.22 | 316.16 | 349.39 | 387.02 | 429.05 | 474.92 | 521.95 | 585.75 |
| Antibody-drug conjugates (ADCs) | 36.53 | 41.99 | 43.55 | 49.06 | 54.22 | 61.00 | 67.69 | 74.77 | 83.31 | 96.57 | 99.57 |
Antibodies Drug Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cancer | 99.81 | 110.61 | 118.95 | 135.93 | 150.27 | 164.54 | 185.27 | 200.12 | 222.42 | 245.78 | 270.48 |
| Autoimmune Diseases | 49.49 | 53.17 | 59.99 | 65.27 | 72.66 | 80.02 | 85.68 | 101.11 | 113.47 | 127.09 | 140.00 |
| Infectious Diseases | 34.74 | 40.10 | 48.00 | 51.14 | 54.72 | 61.08 | 67.58 | 76.20 | 83.26 | 96.94 | 99.84 |
| Inflammatory Diseases | 37.67 | 42.07 | 44.67 | 49.31 | 54.53 | 62.58 | 70.66 | 74.62 | 85.33 | 88.12 | 104.69 |
| Others | 24.04 | 26.34 | 30.08 | 32.64 | 38.21 | 42.17 | 45.53 | 51.77 | 53.75 | 60.58 | 70.31 |
Antibodies Drug Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 147.62 | 164.08 | 182.12 | 200.45 | 224.80 | 248.33 | 270.37 | 306.45 | 340.24 | 372.20 | 412.68 |
| Online Pharmacy | 62.75 | 67.33 | 75.90 | 83.30 | 91.64 | 103.24 | 114.12 | 124.74 | 135.33 | 154.28 | 170.90 |
| Retail Pharmacy | 35.39 | 40.88 | 43.68 | 50.54 | 53.94 | 58.82 | 70.23 | 72.63 | 82.66 | 92.05 | 101.74 |
Antibodies Drug Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 94.68 | 104.67 | 114.69 | 128.18 | 141.55 | 156.48 | 172.82 | 193.25 | 212.05 | 238.55 | 258.82 |
| Europe | 60.59 | 68.02 | 77.64 | 84.65 | 93.49 | 101.11 | 115.97 | 120.40 | 135.83 | 152.96 | 169.80 |
| Asia-Pacific | 46.78 | 52.97 | 59.79 | 65.60 | 74.16 | 82.98 | 90.99 | 99.85 | 113.20 | 121.09 | 136.87 |
| Latin America | 26.26 | 26.86 | 29.55 | 32.68 | 37.52 | 40.66 | 44.87 | 52.82 | 56.30 | 65.54 | 70.60 |
| Middle East & Africa | 17.45 | 19.76 | 20.02 | 23.17 | 23.67 | 29.16 | 30.05 | 37.50 | 40.85 | 40.39 | 49.24 |
Antibody Drug Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
